The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on August 24, 2026

3 hours ago

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Indeterminate GlobeNewswire

3 hours ago

Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

Indeterminate GlobeNewswire

15 hours ago

GOxCALL Turns Any Screen Into a Queue Counter

Indeterminate EIN Presswire

3 hours ago

Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions

Indeterminate GlobeNewswire

3 hours ago

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

Indeterminate GlobeNewswire

3 hours ago

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

3 hours ago

ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE

Indeterminate GlobeNewswire

3 hours ago

AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer

Indeterminate GlobeNewswire

3 hours ago

Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

Indeterminate GlobeNewswire

3 hours ago

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Indeterminate GlobeNewswire

3 hours ago

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

Indeterminate GlobeNewswire

3 hours ago

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Indeterminate GlobeNewswire

3 hours ago

BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™

Indeterminate GlobeNewswire

4 hours ago

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

Indeterminate GlobeNewswire

4 hours ago

Felix Health launches sleep apnea care through new collaboration with MedSleep

Indeterminate GlobeNewswire

4 hours ago

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

Indeterminate GlobeNewswire

4 hours ago

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

4 hours ago

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Indeterminate GlobeNewswire

4 hours ago

Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes

Indeterminate GlobeNewswire